Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Exploring the microcirculatory effects of an exercise programme including aerobic and resistance training in people with limited cutaneous systemic sclerosis.

Mitropoulos A, Gumber A, Akil M, Klonizakis M.

Microvasc Res. 2019 Jun 17;125:103887. doi: 10.1016/j.mvr.2019.103887. [Epub ahead of print]

PMID:
31220505
2.

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Hackett KL, Davies K, Tarn J, Bragg R, Hargreaves B, Miyamoto S, McMeekin P, Mitchell S, Bowman S, Price EJ, Pease C, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2019 Apr 24;5(1):e000885. doi: 10.1136/rmdopen-2018-000885. eCollection 2019.

3.

Nuclear medicine imaging in idiopathic inflammatory myopathies.

Nadin T, Akil M, Shastry M, Hughes M.

Eur J Rheumatol. 2019 Mar 10. doi: 10.5152/eurjrheum.2018.18199. [Epub ahead of print] No abstract available.

PMID:
30978162
4.
5.

Fully Automatic Brain Tumor Segmentation using End-To-End Incremental Deep Neural Networks in MRI images.

Naceur MB, Saouli R, Akil M, Kachouri R.

Comput Methods Programs Biomed. 2018 Nov;166:39-49. doi: 10.1016/j.cmpb.2018.09.007. Epub 2018 Sep 21.

PMID:
30415717
6.

An unusual case of inflammatory meningitis in a young man with systemic lupus erythematosus.

Smith R, Hadjivassiliou M, Hoggard N, Kuet KP, Kilding R, Akil M.

Lupus. 2018 Oct;27(11):1864-1866. doi: 10.1177/0961203318791760. Epub 2018 Aug 9.

PMID:
30092733
7.

Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist.

Snowden JA, Sharrack B, Akil M, Kiely DG, Lobo A, Kazmi M, Muraro PA, Lindsay JO.

Clin Med (Lond). 2018 Aug;18(4):329-334. doi: 10.7861/clinmedicine.18-4-329.

8.

A mobile computer aided system for optic nerve head detection.

Elloumi Y, Akil M, Kehtarnavaz N.

Comput Methods Programs Biomed. 2018 Aug;162:139-148. doi: 10.1016/j.cmpb.2018.05.004. Epub 2018 May 4.

PMID:
29903480
9.

The effects of upper and lower limb exercise on the microvascular reactivity in limited cutaneous systemic sclerosis patients.

Mitropoulos A, Gumber A, Crank H, Akil M, Klonizakis M.

Arthritis Res Ther. 2018 Jun 5;20(1):112. doi: 10.1186/s13075-018-1605-0.

10.

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.

Dumusc A, Ng WF, James K, Griffiths B, Price E, Pease C, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Gupta M, McLaren J, Cooper A, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman S.

Swiss Med Wkly. 2018 Feb 7;148:w14588. doi: 10.4414/smw.2018.14588. eCollection 2018.

11.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.

12.

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.

McCarthy EM, Sutton E, Nesbit S, White J, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2018 Mar 1;57(3):470-479. doi: 10.1093/rheumatology/kex395.

13.

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL.

Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410.

14.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman SJ.

Rheumatology (Oxford). 2017 Dec 1;56(12):2255. doi: 10.1093/rheumatology/kex331. No abstract available.

PMID:
28968900
15.

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.

McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2017 Jun 1;56(6):1049. doi: 10.1093/rheumatology/kex218. No abstract available.

PMID:
28549192
16.

Interaction of glucocorticoids and progesterone derivatives with human serum albumin.

Abboud R, Akil M, Charcosset C, Greige-Gerges H.

Chem Phys Lipids. 2017 Oct;207(Pt B):271-278. doi: 10.1016/j.chemphyslip.2017.04.007. Epub 2017 Apr 21.

PMID:
28435101
17.

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.

McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2017 Jun 1;56(6):1041-1043. doi: 10.1093/rheumatology/kex044. No abstract available. Erratum in: Rheumatology (Oxford). 2017 Jun 1;56(6):1049.

18.

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2017 Jul;76(7):1207-1218. doi: 10.1136/annrheumdis-2016-210503. Epub 2017 Feb 10.

19.

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy.

Bezzina OM, Gallagher P, Mitchell S, Bowman SJ, Griffiths B, Hindmarsh V, Hargreaves B, Price EJ, Pease CT, Emery P, Lanyon P, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper AM, Regan M, Giles IP, Isenberg DA, Saravanan V, Coady D, Dasgupta B, McHugh NJ, Young-Min SA, Moots RJ, Gendi N, Akil M, MacKay K, Ng WF, Robinson LJ; UK Primary Sjögren's Syndrome Registry.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1714-1723. doi: 10.1002/acr.23165. Epub 2017 Oct 9.

20.

Review - Selenium - Its metabolism and relation to exercise.

Baltaci AK, Mogulkoc R, Akil M, Bicer M.

Pak J Pharm Sci. 2016 Sep;29(5):1719-1725. Review.

PMID:
27731835
21.

The utility of the TIMI risk index on admission for predicting angiographic no-reflow after primary percutaneous coronary intervention in patients with STEMI.

Acet H, Ertaş F, Akil MA, Bilik MZ, Aydin M, Polat N, Yildiz A.

Turk J Med Sci. 2016 Apr 19;46(3):604-13. doi: 10.3906/sag-1411-157.

PMID:
27513233
22.

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines.

Howard Tripp N, Tarn J, Natasari A, Gillespie C, Mitchell S, Hackett KL, Bowman SJ, Price E, Pease CT, Emery P, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg DA, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2016 Jul 19;2(2):e000282. doi: 10.1136/rmdopen-2016-000282. eCollection 2016.

23.

Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis.

Bilik MZ, Kaplan İ, Polat N, Akil MA, Akyüz A, Acet H, Yüksel M, İnci Ü, Kayan F, Toprak N.

Medicine (Baltimore). 2016 May;95(18):e3562. doi: 10.1097/MD.0000000000003562.

24.

Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus.

McElhone K, Abbott J, Sutton C, Mullen M, Lanyon P, Rahman A, Yee CS, Akil M, Bruce IN, Ahmad Y, Gordon C, Teh LS.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1505-13. doi: 10.1002/acr.22850. Epub 2016 Sep 2.

25.

Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres.

Akil MA, Bilik MZ, Yildiz A, Acet H, Ertas F, Simsek H, Polat N, Zengin H, Akilli R, Agacayak E, Kayan F, Ozdemir M, Alan S.

J Obstet Gynaecol. 2016 Jul;36(5):574-80. doi: 10.3109/01443615.2015.1107531. Epub 2016 Jan 20.

PMID:
26789488
26.

The Effect of Caffeic Acid Phenethyl Ester (CAPE) Fortification on the Liver Element Distribution that Occurs After Exercise.

Akil M, Coban FK, Yalcinkaya O.

Biol Trace Elem Res. 2016 Aug;172(2):419-23. doi: 10.1007/s12011-015-0608-9. Epub 2016 Jan 8.

PMID:
26743862
27.

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.

James K, Al-Ali S, Tarn J, Cockell SJ, Gillespie CS, Hindmarsh V, Locke J, Mitchell S, Lendrem D, Bowman S, Price E, Pease CT, Emery P, Lanyon P, Hunter JA, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B; UK Primary Sjögren’s Syndrome registry, Wipat A, Newton J, Jones DE, Isaacs J, Hallinan J, Ng WF.

PLoS One. 2015 Dec 22;10(12):e0143970. doi: 10.1371/journal.pone.0143970. eCollection 2015.

28.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman SJ; UK Primary Sjögren’s Syndrome Registry.

Rheumatology (Oxford). 2016 Mar;55(3):544-52. doi: 10.1093/rheumatology/kev373. Epub 2015 Oct 27. Erratum in: Rheumatology (Oxford). 2017 Dec 1;56(12 ):2255.

29.

Apelin Levels In Isolated Coronary Artery Ectasia.

Bilik MZ, Kaplan İ, Yıldız A, Akıl MA, Acet H, Yüksel M, Polat N, Aydın M, Oylumlu M, Ertaș F, Kaya H, Alan S.

Korean Circ J. 2015 Sep;45(5):386-90. doi: 10.4070/kcj.2015.45.5.386. Epub 2015 May 13.

30.

Association between the neutrophil to lymphocyte ratio and prehypertension.

Aydin M, Yuksel M, Yildiz A, Polat N, Bilik MZ, Akil MA, Acet H, Demir M, Inci U, Toprak N.

Bratisl Lek Listy. 2015;116(8):475-9.

PMID:
26350086
31.

C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis.

Muthana M, Hawtree S, Wilshaw A, Linehan E, Roberts H, Khetan S, Adeleke G, Wright F, Akil M, Fearon U, Veale D, Ciani B, Wilson AG.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11618-23. doi: 10.1073/pnas.1501947112. Epub 2015 Aug 27.

32.

The relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention.

Acet H, Ertaş F, Bilik MZ, Akıl MA, Özyurtlu F, Aydın M, Oylumlu M, Polat N, Yüksel M, Yıldız A, Kaya H, Akyüz A, Ayçiçek H, Özbek M, Toprak N.

Postepy Kardiol Interwencyjnej. 2015;11(2):126-35. doi: 10.5114/pwki.2015.52286. Epub 2015 Jun 22.

33.

Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis.

Hawtree S, Muthana M, Wilkinson JM, Akil M, Wilson AG.

Hum Mol Genet. 2015 Oct 1;24(19):5367-77. doi: 10.1093/hmg/ddv258. Epub 2015 Jul 7.

PMID:
26152200
34.

Identifying autonomic nervous system dysfunction in acute cerebrovascular attack by assessments of heart rate variability and catecholamine levels.

Akıl E, Tamam Y, Akıl MA, Kaplan İ, Bilik MZ, Acar A, Tamam B.

J Neurosci Rural Pract. 2015 Apr-Jun;6(2):145-50. doi: 10.4103/0976-3147.153216.

35.

The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary intervention.

Acet H, Ertaş F, Bilik MZ, Aydın M, Yüksel M, Polat N, Yıldız A, Özyurtlu F, Akıl MA, Çiftçi L, Özbek M, Alan S, Toprak N.

Ther Adv Cardiovasc Dis. 2015 Oct;9(5):257-66. doi: 10.1177/1753944715574814. Epub 2015 Mar 16.

PMID:
25784498
36.

Selenium prevents lipid peroxidation in liver and lung tissues of rats in acute swimming exercise.

Akil M, Gurbuz U, Bicer M, Halifeoglu I, Baltaci AK, Mogulkoc R.

Bratisl Lek Listy. 2015;116(4):233-5.

PMID:
25773950
37.

Effect of melatonin on element distribution in the liver tissue of diabetic rats subjected to forced exercise.

Bicer M, Akil M, Baltaci AK, Mogulkoc R, Sivrikaya A, Akkus H.

Bratisl Lek Listy. 2015;116(2):119-23.

PMID:
25665479
38.

The prognostic significance of serum albumin in patients with acute decompensated systolic heart failure.

Polat N, Aydin M, Yildiz A, Acet H, Akil MA, Bilik MZ, Demir M, Isik MA, Kaya H, Alan S.

Acta Cardiol. 2014 Dec;69(6):648-54.

PMID:
25643435
39.

[Assessment of right ventricular systolic function in patients with chronic renal failure before and after hemodialysis by means of various echocardiographic modalities].

Akyüz A, Yıldız A, Akıl MA, Bilik MZ, İnci Ü, Kayan F, Yıldız İ, Yılmaz Z, Yıldırım Y, Ülgen MS.

Turk Kardiyol Dern Ars. 2014 Dec;42(8):717-25. doi: 10.5543/tkda.2014.57609. Turkish.

40.

Novel predictors of infarct-related artery patency for ST-segment elevation myocardial infarction: Platelet-to-lymphocyte ratio, uric acid, and neutrophil-to-lymphocyte ratio.

Acet H, Ertaş F, Akıl MA, Özyurtlu F, Yıldız A, Polat N, Bilik MZ, Aydın M, Oylumlu M, Kaya H, Yüksel M, Akyüz A, Ayçiçek H, Alan S, Toprak N.

Anatol J Cardiol. 2015 Aug;15(8):648-56. doi: 10.5152/akd.2014.5592. Epub 2014 Jul 11.

41.

The relationship between atrial electromechanical delay and left atrial mechanical function in stroke patients.

Akıl MA, Akıl E, Bilik MZ, Oylumlu M, Acet H, Yıldız A, Akyüz A, Ertaş F, Toprak N.

Anatol J Cardiol. 2015 Jul;15(7):565-70. doi: 10.5152/akd.2014.5558. Epub 2014 Jun 3.

42.

Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?

McElhone K, Burnell J, Sutton C, Abbott J, Lanyon P, Rahman A, Yee CS, Akil M, Ahmad Y, Bruce IN, Gordon C, Teh LS.

Value Health. 2014 Nov;17(7):A538. doi: 10.1016/j.jval.2014.08.1725. Epub 2014 Oct 26. No abstract available.

43.

Assessment of atrial electromechanical delay and P-wave dispersion in patients with psoriasis.

Yildiz A, Ucmak D, Oylumlu M, Akkurt MZ, Yuksel M, Akil MA, Acet H, Polat N, Aydin M, Bilik MZ.

Echocardiography. 2014 Oct;31(9):1071-6. doi: 10.1111/echo.12530. Epub 2014 Feb 7.

PMID:
25271546
44.

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

Lendrem D, Mitchell S, McMeekin P, Gompels L, Hackett K, Bowman S, Price E, Pease CT, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Ng WF; UK primary Sjögren’s Syndrome Registry.

Rheumatology (Oxford). 2015 Apr;54(4):655-9. doi: 10.1093/rheumatology/keu361. Epub 2014 Sep 19.

45.

Echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio are novel inflammatory predictors of cerebral ischemic stroke.

Akıl E, Akıl MA, Varol S, Özdemir HH, Yücel Y, Arslan D, Akyüz A, Alan S.

J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2328-34. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.028. Epub 2014 Sep 6.

PMID:
25200242
46.

The association between the neutrophil/lymphocyte ratio and functional capacity in patients with idiopathic dilated cardiomyopathy.

Yıldız A, Yüksel M, Oylumlu M, Polat N, Akıl MA, Acet H.

Anatol J Cardiol. 2015 Jan;15(1):13-7. doi: 10.5152/akd.2014.5131. Epub 2014 Feb 10.

47.

Case images: A co-anomaly: hourglass-like aorta and giant coronary arteries.

Akıl MA, Bilik MZ, Acet H, Ertaş F, Yıldız A.

Turk Kardiyol Dern Ars. 2014 Jul;42(5):498. doi: 10.5543/tkda.2014.09158. No abstract available.

48.

A novel predictor of infarct-related artery patency before percutaneous intervention and in-hospital outcomes for ST-segment elevation myocardial infarction patients: serum bilirubin level.

Acet H, Ertş F, Akıl MA, Polat N, Aydın M, Akyüz A, Ayçiçek H, Alan S.

Postepy Kardiol Interwencyjnej. 2014;10(2):91-7. doi: 10.5114/pwki.2014.43513. Epub 2014 Jun 26.

49.

Attitudes toward neuroscience education in psychiatry: a national multi-stakeholder survey.

Fung LK, Akil M, Widge A, Roberts LW, Etkin A.

Acad Psychiatry. 2015 Apr;39(2):139-46. doi: 10.1007/s40596-014-0183-y. Epub 2014 Jul 8.

PMID:
25001432
50.

Visceral fat reflects disease activity in patients with ankylosing spondylitis.

Aydin M, Aydin F, Yuksel M, Yildiz A, Polat N, Akil MA, Bilik MZ, Akyuz A, Batmaz I, Alan S.

Clin Invest Med. 2014 Jun 1;37(3):E186.

PMID:
24895992

Supplemental Content

Support Center